Abolis Biotechnologies

Natural ingredients are evolving and biotechnology is helping shape what comes next. Abolis Biotechnologies was delighted to contribute to Personal Care Insights’ latest article on beauty ingredients, sustainability, and supply chain resilience. 📖 Discover the full piece here:  https://lnkd.in/gPpCr7Eu

👋 As demand grows for microbial biotechnology that can move from first insight to industrial-grade solution, Abolis is continuing to strengthen the team supporting partners across Europe and the US. This month, we’re pleased to welcome Vanessa Rouaud, who joins Abolis as Business Development Manager, Europe. Her arrival strengthens our ability to connect with companies exploring how microbial biotechnology can support product innovation, process optimisation, supply-chain resilience and more scalable production routes. Abolis works with partners across healthcare, cosmetics, nutrition, agriculture and specialty chemicals, helping teams move from complex biological questions to clearer development strategies. That requires more than technical capability. It requires the right conversations with the right teams, from early challenge framing through to feasibility, development and scale-up thinking. We’re excited to welcome Vanessa to the team as Abolis continues to grow its international presence and support more partners in bringing industrial-grade biotech solutions closer to application. Welcome to Abolis, Vanessa. #TeamAbolis #BusinessDevelopment #IndustrialBiotech #MicrobialBiotechnology #Innovation #Biomanufacturing #Abolis

📍 Thank you to everyone who connected with Abolis during IFT Chicago. The event brought together valuable conversations across food, nutrition, ingredient innovation and fermentation-enabled product development. One theme stood out across the week: ingredient innovation is increasingly being discussed through the lens of application. Teams are not only looking for new bio-based routes. They are looking for routes that can support product performance, supply-chain resilience, process robustness and commercial relevance. It reflects where microbial biotechnology can create value for food and nutrition companies: not only by identifying what biology can do, but by developing routes that can move closer to validated, scalable solutions. At Abolis, this connects strongly with how we work from ideation to scale. We help partners assess the biological route, understand the microbial system, optimise the process and prepare projects for real industrial constraints. Thank you again to the partners, R&D teams and industry contacts who shared their perspectives with us at IFT Chicago. Felipe Sarmiento, PhD, MBA #IFTChicago #FoodInnovation #IngredientInnovation #MicrobialBiotechnology #Fermentation #IndustrialBiotech #Abolis

Microbial technology has a lot of potential, but this can be difficult to harness. A promising biological insight still needs the right organism, the right process, the right analytical approach, the right IP position and the right scale-up pathway. Without that connected development route, a project can remain a technical result rather than becoming an industrial-grade biotech solution. This is why industrial biotech needs more than discovery. It needs partners that can help connect scientific depth with industrial application. At Abolis, we support partners from first insight through to validated development routes, bringing together microbial engineering, fermentation, analytics, microbial intelligence, process development, IP expertise and scale-up support. That end-to-end perspective matters because each project has its own constraints. A molecule may need a more secure production route. A process may need to become more competitive. A microbial system may need to be better understood. A product brief may need the right biological strategy before development can begin. In each case, the value comes from knowing how to move from possibility to action. Exploring a microbial biotech development challenge? Speak with the Abolis team to discuss how we can support the route from first insight to industrial-grade solution. #IndustrialBiotech #MicrobialBiotechnology #Fermentation #Bioprocessing #ScaleUp #Innovation #Abolis

In microbial biotechnology, the starting point matters. Many projects begin with a scientific opportunity, a target molecule, a microbial system, a product brief or an industrial challenge that needs a better route. But before development can move in the right direction, the challenge needs to be clearly understood. What is the project really trying to solve? Is the priority product performance, supply-chain resilience, yield improvement, process robustness, cost competitiveness, scale-up potential or a clearer understanding of a microbial ecosystem? This influences which route to explore, which capabilities to bring together, which constraints to anticipate and which decisions need to be made early. At Abolis, microbial biotechnology starts from the industrial challenge, not the technology in isolation. We work with partners to frame the opportunity, assess the development route and connect scientific depth with industrial application. That approach helps turn complex biological questions into clearer strategies, so teams can move from first insight towards solutions that are scalable, relevant and aligned with real business needs. Exploring a microbial biotech development challenge? Speak with the Abolis team to discuss where to begin. #IndustrialBiotech #MicrobialBiotechnology #Fermentation #Bioprocessing #ResearchAndDevelopment #Innovation #Abolis

📍 Felipe Sarmiento, PhD, MBA will be attending IFT FIRST Chicago later this month, connecting with companies and innovators across food, nutrition and ingredient development. Across the food and nutrition sectors, more teams are looking at microbial biotechnology as a way to rethink how ingredients are discovered, developed and produced. For some companies, the challenge is creating a new bio-based ingredient. For others, it is improving product performance, building a more reliable supply chain, increasing yield, or developing a production route that can become more robust and competitive. At Abolis, we support partners from first insight to industrial-grade biotech solutions, combining deep microbial biotech expertise, microbial intelligence, proprietary tools, fermentation capabilities, analytics, scale-up support and IP expertise. We look forward to meeting teams exploring how microbial biotechnology can support the next generation of food, nutrition and ingredient innovation. Interested in meeting Felipe at IFT Chicago? Get in touch with the Abolis team here: https://lnkd.in/ei-vVsx9 #IFTChicago #FoodInnovation #IngredientInnovation #MicrobialBiotechnology #Fermentation #IndustrialBiotech #Abolis

In microbial biotechnology, early technical success is only useful if it can survive the next development stage. That is why scale-up thinking has to be built into the project early, from strain selection and process design through to economics, IP and industrial transfer. 🧬 A promising organism or pathway is only one part of the equation. To move towards industrial application, the biology, process, economics and production pathway all need to fit together. The process needs to be robust, the conditions need to be realistic, the economics need to be credible and the scale-up route needs to be carefully prepared. This is often where microbial biotechnology becomes most complex. A project may begin with a target molecule, a new ingredient brief, a supply-chain challenge, a process that needs to become more competitive, or a microbial system that needs to be better understood. With each project, the goal is to identify a biological route that can keep performing as it moves closer to production. At Abolis, we support this journey from first insight to real-world industrial application. 🔬 We bring together strain construction, robotics, protein modelling, analytics, bioprocess development, IP expertise and scale-up support to help partners assess feasibility, develop the right biological system, optimise the process and prepare for transfer with trusted industrial partners. Scale-up is not just a final step added at the end, it needs to be anticipated throughout the development path. This allows microbial biotechnology to move from a technical result to an industrial-grade biotech solution. #IndustrialBiotech #ScaleUp #Fermentation #Bioprocessing #MicrobialEngineering #Biomanufacturing #Abolis

We’re pleased to share that we’ve joined the iFAB Tech Hub as a strategic partner. iFAB is building a strong biomanufacturing and precision fermentation ecosystem in Central Illinois, connecting regional agricultural assets, bioprocessing infrastructure, research leadership and industry partners to help more technologies progress beyond the lab. In microbial biotechnology, industrial relevance depends on more than an early technical result. It depends on the ability to connect biological performance with process robustness, scale-up thinking and real-world application. At Abolis, we support partners from first insight to industrial-grade biotech solutions, bringing together deep microbial biotech expertise, microbial intelligence, proprietary tools, fermentation capabilities, analytics, scale-up support and IP expertise. Through this strategic partnership, we look forward to contributing to iFAB’s mission and engaging with a growing network of innovators across the biomanufacturing value chain. The partnership also creates new opportunities for our customers and partners seeking biomanufacturing solutions in the United States, providing access to infrastructure, expertise, and collaborative pathways that can help accelerate scale-up and industrial deployment. Thank you to the iFAB team for the warm welcome. 🤝 #IndustrialBiotech #MicrobialBiotechnology #Biomanufacturing #PrecisionFermentation #Fermentation #ScaleUp #Abolis

📍 Later this month, Gwenaël Servant and Felipe Sarmiento, PhD, MBA will be in Japan for a series of meetings and industry conversations with companies exploring microbial biotechnology. The trip comes at an important moment for the field. Across healthcare, cosmetics, nutrition and industrial applications, more teams are looking at biology as a way to rethink how products are discovered, developed and produced. For some companies, the opportunity is a new bio-based ingredient. For others, it is a more secure route to a high-value molecule, a better understanding of a microbial ecosystem, or a fermentation process that needs to become more robust and competitive. What connects these conversations is the need to make microbial biotechnology practical. Abolis brings together more than a decade of microbial biotech expertise, proprietary tools, fermentation and analytical capabilities, process development experience and scale-up support to help partners move from an initial challenge to a clearer development route. We are looking forward to meeting partners, R&D teams and innovators in Japan to discuss how microbial intelligence and industrial biotech can support the next generation of product and process innovation. #IndustrialBiotech #MicrobialBiotechnology #Microbiome #Fermentation #Innovation #Japan #Abolis

In microbial biotechnology, the most useful insight is rarely a simple list of what is present. Microbial systems are complex, shaped by organisms, pathways, metabolites, environmental conditions and interactions that are constantly influencing one another. The challenge is not only to generate more biological data, but to also understand what that data means, how it connects, and where it can guide the next step. This is where microbial intelligence matters. At Abolis, microbial intelligence means deciphering microbial systems and turning complexity into clear, actionable strategies. It is the ability to connect biological assets, experimental data, strain histories, process knowledge and multi-omics insights into a more complete view of what is happening inside a microbial system. That clarity helps teams move beyond observation and towards better decisions, like which route to explore, which parameters to test, which biological functions matter, and how to move a project closer to a validated solution. This is why we’ve developed proprietary tools and data-driven workflows designed to accelerate development, improve traceability and maintain excellence at every stage of the project. 🔬 Microbial intelligence is not only about seeing more, it’s about understanding what matters and knowing what to do next. Find out more here: https://lnkd.in/eYwN8exa  #MicrobialIntelligence #MicrobialBiotechnology #MultiOmics #IndustrialBiotech #Microbiome #ResearchAndDevelopment #Abolis